№ lp_2_2_03382
File format: docx Character count: 71327 File size: 720 KB
This document provides supplementary details on methods, metabolomic profiling, and data analysis for identifying non-diabetic CP patients at risk of progressing to prediabetes through plasma metabolite profiling.
Year: 2023
Region / City: Hyderabad, Telangana, India
Subject: Metabolomics, Plasma Profiling, Pre-Diabetes, Non-Diabetic CP Patients
Document Type: Supplementary Information
Organization / Institution: Translational Research Centre, Asian Healthcare Foundation, AIG Hospitals, CSIR-Indian Institute of Chemical Technology
Authors: Ketavarapu Vijayasarathy, Addipilli Ramunaidu, Nagarjunachary Ragi, Pallerla Pavankumar, Venu Simhadri, Suvidha Manne, Sannapaneni Krishnaiah, Mohsin Aslam, Rupjyoti Talukadar, Ch. Venkataramana Devi, G.V. Rao, Ramars Amanchy, D. Nageshwar Reddy, Prabhakar Sripadi, Mitnala Sasikala
Target Audience: Researchers, Healthcare professionals in metabolomics and diabetes research
Period of Validity: Not specified
Approval Date: Not specified
Date of Changes: Not specified
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Search strategy for identifying studies on prediabetes and gastric neoplasms in PubMed, Embase, and Web of Science
Year: 2026
Databases: PubMed, Embase, Web of Science
Topic: Prediabetes and gastric cancer
Document type: Research search strategy
Target audience: Medical researchers, epidemiologists
Keywords: prediabetes, prediabetic, pre-diabetes, impaired fasting glucose, impaired glucose tolerance, HbA1c, fasting glucose, gastric, stomach, neoplasms, cancer, tumor, carcinoma, adenoma, malignancy
Purpose: Identification of relevant literature for systematic review or meta-analysis
Business Rules for Quality and Outcomes Framework (QOF) 2023–2024 and 2024–2025: Non-diabetic hyperglycaemia
Author: General Practice Specification and Extraction Service (GPSES), NHS England
Publisher: NHS England
Type of document: Business rules specification
Programme: Quality and Outcomes Framework (QOF)
Clinical area: Non-diabetic hyperglycaemia
Version: 49.0
Version date: 01 April 2024
Initial publication date: 01 April 2020
Applicable period: 01 April 2023 – 31 March 2025
Intended users: GP system suppliers, NHS England, GP practices
Geographic scope: England
Data source: Primary Care systems
Update frequency: Annual
Technical reference: Clinical and drug reference sets (refsets)
CGMap - Characterizing Continuous Glucose Monitor Data in Non-Diabetic Adults Aged 40-70 Years (2019-2022)
Year: 2019-2022
Region / City: Israel
Topic: Continuous Glucose Monitoring, Non-Diabetic Population
Document Type: Research Article
Institution: Weizmann Institute of Science, Tel Aviv University, Rabin Medical Center, Pheno.AI
Authors: Ayya Keshet, Smadar Shilo, Anastasia Godneva, Yeela Talmor-Barkan, Yaron Aviv, Eran Segal, Hagai Rossman
Target Audience: Researchers, Clinicians
Study Population: 7,104 non-diabetic adults, aged 40-70, 45.7% male, 54.3% female
Methodology: Continuous Glucose Monitoring, blood tests, DXA scans, food intake logging, sleep monitoring
Key Measurements: Mean blood glucose, glucose variability, clinical measures related to cardiovascular health, nutrition, and sleep
Lead Contact: Dr. Hagai Rossman
Corresponding Author: Prof. Eran Segal
Purpose: Establish reference values for CGM-derived metrics in a healthy population
Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%)
Year: Not specified
Region / City: Not specified
Topic: Health / Medical
Document Type: Medical guideline
Author: Not specified
Target Audience: Healthcare professionals
Action Period: Not specified
Approval Date: Not specified
Date of Changes: Not specified
HbA1c for Monitoring of Diabetes Mellitus
Note: Year
Competency Statement for Abbott Afinion 2 HbA1c Analyser Users
Year: 2026
Organization: Abbott Laboratories
Document Type: Competency Assessment Form
Region / Location: Not specified
Intended Audience: Laboratory and clinical staff using the Afinion 2 analyser
Subject: HbA1c measurement and analyser operation
Method: Boronate affinity assay
Assessment Date: Not specified
Trainer / Assessor: Senior nurse or manufacturer trainer
Sample Type: Finger prick whole blood
Quality Control: Preparation and analysis of QC specimens included
Topics: prediabetes Non-diabetic HbA1c